Oncolytics Biotech Inc. logo

Oncolytics Biotech Inc.

NASDAQ:ONCY

Overview | Financials
Company Name Oncolytics Biotech Inc.
Symbol ONCY
Currency USD
Price 1.11
Market Cap 83,715,978
Dividend Yield 0%
52-week-range 0.88 - 3.39
Industry Biotechnology
Sector Healthcare
CEO Dr. Matthew C. Coffey M.B.A., Ph.D.
Website https://www.oncolyticsbiotech.com

An error occurred while fetching data.

About Oncolytics Biotech Inc.

Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA

Related Stocks

Qilian International Holding Group Limited logo

Qilian International Holding Group Limited

QLI

0.72 USD

Bolt Biotherapeutics, Inc. logo

Bolt Biotherapeutics, Inc.

BOLT

0.775 USD

SCYNEXIS, Inc. logo

SCYNEXIS, Inc.

SCYX

2.67 USD

Seelos Therapeutics, Inc. logo

Seelos Therapeutics, Inc.

SEEL

1.63 USD

Entera Bio Ltd. logo

Entera Bio Ltd.

ENTX

2.39 USD

Bionomics Limited logo

Bionomics Limited

BNOX

1.18 USD

Rain Therapeutics Inc. logo

Rain Therapeutics Inc.

RAIN

1.21 USD

Financials

Numbers are in millions USD

Numbers are in millions USD